                         SEQUENCE LISTING

<110>  Arrowhead Pharmaceuticals, Inc.
       Carlson, Jeffrey  C
       Blokhin, Andrei V
 
<120>  Biologically Cleavable Tetrapeptide Linking Agents

<130>  30630-WO1

<150>  62168244
<151>  2015-05-29

<150>  62235833
<151>  2015-10-01

<160>  19    

<170>  PatentIn version 3.5

<210>  1
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  tetrapeptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa = Citrulline

<400>  1

Ala Xaa Ala Ala 
1               


<210>  2
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  tetrapeptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa = citrulline

<400>  2

Ala Xaa Ala Pro 
1               


<210>  3
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  tetrapeptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa = citrulline

<400>  3

Ala Xaa Phe Pro 
1               


<210>  4
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Factor 7 siRNA sense strand


<220>
<221>  modified_base
<222>  (1)..(19)
<223>  ribonucleotide

<400>  4
gcaaaggcgu gccaacucat                                                   20


<210>  5
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  tetrapeptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Xaa = Citrulline

<400>  5

Xaa Ala Ala Ala 
1               


<210>  6
<211>  21
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Factor 7 siRNA antisense strand


<220>
<221>  modified_base
<222>  (2)..(19)
<223>  ribonucleotide

<400>  6
tgaguuggca cgccuuugct t                                                 21


<210>  7
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  tetrapeptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa = Citrulline

<400>  7

Phe Xaa Ala Ala 
1               


<210>  8
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  tetrapeptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa = Citrulline

<400>  8

Phe Xaa Ala Pro 
1               


<210>  9
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  tetrapeptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa = Citrulline

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa = N-methyl alanine

<400>  9

Phe Xaa Phe Xaa 
1               


<210>  10
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  tetrapeptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa = Citrulline

<400>  10

Phe Xaa Phe Ala 
1               


<210>  11
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  tetrapeptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa = Citrulline

<400>  11

Phe Xaa Phe Leu 
1               


<210>  12
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  tetrapeptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa = Citrulline

<400>  12

Phe Xaa Phe Pro 
1               


<210>  13
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  tetrapeptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa = Citrulline

<400>  13

Phe Xaa Val Pro 
1               


<210>  14
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  tetrapeptide

<400>  14

Phe Asp Phe Pro 
1               


<210>  15
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  tetrapeptide

<400>  15

Phe Lys Phe Leu 
1               


<210>  16
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  tetrapeptide

<400>  16

Phe Lys Phe Pro 
1               


<210>  17
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  tetrapeptide

<400>  17

Phe Asn Phe Pro 
1               


<210>  18
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  tetrapeptide

<400>  18

Gly Phe Leu Gly 
1               


<210>  19
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  tetrapeptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa = Citrulline

<400>  19

Val Xaa Phe Pro 
1               


